These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 15752936

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population.
    Talwar S, Squire IB, Davies JE, Barnett DB, Ng LL.
    Eur Heart J; 1999 Dec; 20(23):1736-44. PubMed ID: 10562482
    [Abstract] [Full Text] [Related]

  • 23. Neurohormonal activation and diagnostic value of cardiac peptides in patients with suspected mild heart failure.
    Mikkelsen KV, Bie P, Møller JE, Videbaek L, Villadsen HD, Haghfelt T.
    Int J Cardiol; 2006 Jun 28; 110(3):324-33. PubMed ID: 16213609
    [Abstract] [Full Text] [Related]

  • 24. BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction.
    Grewal J, McKelvie R, Lonn E, Tait P, Carlsson J, Gianni M, Jarnert C, Persson H.
    Eur J Heart Fail; 2008 Mar 28; 10(3):252-9. PubMed ID: 18331967
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Population-based detection of systolic and diastolic dysfunction with amino-terminal pro-B-type natriuretic peptide.
    Abhayaratna WP, Marwick TH, Becker NG, Jeffery IM, McGill DA, Smith WT.
    Am Heart J; 2006 Nov 28; 152(5):941-8. PubMed ID: 17070165
    [Abstract] [Full Text] [Related]

  • 27. Left ventricular dysfunction screening in hypertensive patients with N-terminal pro-B-type natriuretic peptide and electrocardiogram.
    Limkakeng AT, Drake W, Mani G, Freeman D, Best R, Newby LK, Chandra A.
    Am J Emerg Med; 2012 Jan 28; 30(1):214-7. PubMed ID: 21185671
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Comparative value of BNP and NT-proBNP in diagnosis of heart failure.
    Fonseca C, Sarmento PM, Minez A, Gonçalves E, Covas R, Dias AR, Pina MJ, Ceia F.
    Rev Port Cardiol; 2004 Jan 28; 23(7-8):979-91. PubMed ID: 15478324
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction.
    Maisel AS, Koon J, Krishnaswamy P, Kazenegra R, Clopton P, Gardetto N, Morrisey R, Garcia A, Chiu A, De Maria A.
    Am Heart J; 2001 Mar 28; 141(3):367-74. PubMed ID: 11231433
    [Abstract] [Full Text] [Related]

  • 33. Left ventricular end diastolic pressure and serum brain natriuretic peptide levels in patients with abnormal impedance cardiography parameters.
    Velazquez-Cecena JL, Sharma S, Nagajothi N, Khraisat A, Khosla S, Arora RR, Benatar D.
    Arch Med Res; 2008 May 28; 39(4):408-11. PubMed ID: 18375252
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes.
    Epshteyn V, Morrison K, Krishnaswamy P, Kazanegra R, Clopton P, Mudaliar S, Edelman S, Henry R, Maisel A.
    Diabetes Care; 2003 Jul 28; 26(7):2081-7. PubMed ID: 12832317
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Screening for asymptomatic left ventricular systolic dysfunction in high-risk patients. Preliminary experience with a program based on the use of ECG and natriuretic peptide].
    Tarantini L, Cioffi G, Di Lenarda A, Valle R, Pulignano G, Del Sindaco D, Frigo G, Soravia G, Tessier R, Catania G.
    G Ital Cardiol (Rome); 2008 Dec 28; 9(12):835-43. PubMed ID: 19119693
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Pericardial fluid and serum biomarkers equally predict ventricular dysfunction.
    Amjad S, Sami SA, Basir MN, Hameed K, Fujita M, Ahmad HR.
    Asian Cardiovasc Thorac Ann; 2013 Apr 28; 21(2):160-5. PubMed ID: 24532613
    [Abstract] [Full Text] [Related]

  • 40. The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure.
    Fuat A, Murphy JJ, Hungin AP, Curry J, Mehrzad AA, Hetherington A, Johnston JI, Smellie WS, Duffy V, Cawley P.
    Br J Gen Pract; 2006 May 28; 56(526):327-33. PubMed ID: 16638247
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.